Abbott LaboratoriesGiá xuống
Интересно посмотреть на продажу Abbott Laboratories от 44.50$
Cập nhật
Новость:
Patients who received Abbott Laboratories' novel dissolving vascular stent had a significantly higher rate of serious adverse heart events than those treated with the company's widely used Xience drug-coated metal stent two years after implantation, according to data presented on Saturday.
The U.S. Food and Drug Administration said it was informing healthcare providers of the increased rate of major adverse cardiac events observed in patients receiving Absorb in the study. The agency said it will continue to monitor Absorb's performance in clinical studies and reports submitted to it.
Источник By Bill Berkrot | WASHINGTON:
reuters.com/article/us-heart-abbott-stent-idUSKBN16P0IV?type=companyNews
Patients who received Abbott Laboratories' novel dissolving vascular stent had a significantly higher rate of serious adverse heart events than those treated with the company's widely used Xience drug-coated metal stent two years after implantation, according to data presented on Saturday.
The U.S. Food and Drug Administration said it was informing healthcare providers of the increased rate of major adverse cardiac events observed in patients receiving Absorb in the study. The agency said it will continue to monitor Absorb's performance in clinical studies and reports submitted to it.
Источник By Bill Berkrot | WASHINGTON:
reuters.com/article/us-heart-abbott-stent-idUSKBN16P0IV?type=companyNews
Giao dịch đang hoạt động
Đóng lệnh: đạt mục tiêu
Thông báo miễn trừ trách nhiệm
Thông tin và ấn phẩm không có nghĩa là và không cấu thành, tài chính, đầu tư, kinh doanh, hoặc các loại lời khuyên hoặc khuyến nghị khác được cung cấp hoặc xác nhận bởi TradingView. Đọc thêm trong Điều khoản sử dụng.